.Novo Nordisk is continuing its push into hereditary medicines, agreeing to pay NanoVation Therapeut...
.Innovent Biologics has actually produced the scenario that its own checkpoint inhibitor-cytokine bl...
.A period 3 trial of Daiichi Sankyo as well as Merck & Co.'s HER3-directed antibody-drug conjugat...
.Five months after Rakovina Therapies turned toward expert system, the cancer-focused biotech has ac...
.Ascendis Pharma has become a prospective risk to BioMarin's Voxzogo, reporting stage 3 development ...
.Though Alkeus Pharmaceuticals' dental eye health condition possession failed to dramatically lessen...
.With a trio of biotechs hitting the Nasdaq on Friday, it was effortless to miss out on a smaller-sc...
.Invulnerable checkpoint preventions are the superheroes of cancer cells therapy. Medications like B...
.Accept to today's Chutes & Ladders, our summary of significant management hirings, shootings and...
.Regeneron is back with long-lasting consequence for its own LAG-3 inhibitor and PD-1 inhibitor comb...